BackBiondvax Pharmaceuticals Overview

Biondvax Pharmaceuticals Operating Income

Operating Income for BVXV.

Quarterly Operating Income

$-2595000.00
↓ 75.93% YoY

As of Jun 30, 2023

Annual Operating Income (TTM)

$-8710368.00
↓ 77.22% YoY

Trailing 12 months ending Jun 30, 2023

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin